Early MinIon Mania

In spite of some stumbles and limitations on the technology, early users are gaga over Oxford Nanopore Technologies' MinIon sequencer, Nature News reports.

"This is democratization of sequencing," Joshua Quick, a bioinformatician at the UK's University of Birmingham, told the publication. "You don't have to rely on expensive infrastructure and costly equipment." 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.